Evidence map›Paper›PMID 33523895›Full record

ArticleScience advances2021

The Rab32/BLOC-3-dependent pathway mediates host defense against different pathogens in human macrophages.

Massimiliano Baldassarre, Virtu Solano-Collado, Arda Balci, Rosa A Colamarino, Ivy M Dambuza, Delyth M Reid, Heather M Wilson, Gordon D Brown, Subhankar Mukhopadhyay, Gordon Dougan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. mSphere · 2024
    Article
  7. Article
  8. Article
  9. mBio · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. VARP and Rab9 Are Dispensable for the Rab32/BLOC-3 DependentFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Massimiliano BaldassarreInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK. massimiliano.baldassarre@abdn.ac.uk.ORCID 0000-0002-2498-4767
Virtu Solano-ColladoInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.ORCID 0000-0003-1035-2846
Arda BalciInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.ORCID 0000-0003-1887-821X
Rosa A ColamarinoInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.ORCID 0000-0001-9171-2684
Ivy M DambuzaInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.
Delyth M ReidInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.
Heather M WilsonInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.ORCID 0000-0002-1407-7274
Gordon D BrownInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.
Subhankar MukhopadhyayMRC Centre for Transplantation, Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, Great Maze Pond, London, SE1 9RT, UK.ORCID 0000-0002-7110-6473
Gordon DouganWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Stefania SpanòInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.
University of Aberdeen · GBKing's College London · GBWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages provide a first line of defense against microorganisms, and while some mechanisms to kill pathogens such as the oxidative burst are well described, others are still undefined or unknown. Here, we report that the Rab32 guanosine triphosphatase and its guanine nucleotide exchange factor BLOC-3 (biogenesis of lysosome-related organelles complex-3) are central components of a trafficking pathway that controls both bacterial and fungal intracellular pathogens. This host-defense mechanism is active in both human and murine macrophages and is independent of well-known antimicrobial mechanisms such as the NADPH (reduced form of nicotinamide adenine dinucleotide phosphate)-dependent oxidative burst, production of nitric oxide, and antimicrobial peptides. To survive in human macrophages,

Indexed as

rab GTP-Binding ProteinsSalmonella typhiAnimalsGuanine Nucleotide Exchange FactorsHumansLysosomesMacrophagesMammalsMiceGuanine Nucleotide Exchange FactorsRab32 protein, humanRab32 protein, mouserab GTP-Binding Proteins

Identifiers

PMID33523895
PMCPMC7810368
OpenAlexW3123908254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.